Imago BioSciences, Inc. Alternatives & Competitors

12 companies similar to Imago BioSciences, Inc. — Pioneering innovative therapies to conquer challenging diseases, enabling patien...

Evommune

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 $493.00M

Palo Alto, United States

Biotechnology Health Care +1

AGY Therapeutics

Pioneering breakthrough treatments for central nervous system diseases through innovative...

Series C $22.00M

Biopharma Biotechnology +1

AAVantgarde

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...

70 Series A

Biotechnology Health Care +1

Rezolute, Inc.

Rezolute is developing transformative therapeutics for rare and metabolic diseases.

66 Post-IPO Equity $356.00M

Redwood City, United Stat...

Biotechnology Health Care +1

Track all Imago BioSciences, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Solu Therapeutics

Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...

23 Series A $72.00M

Boston, United States

Biotechnology Health and Wellness

Visterra Inc.

We bring better biologics to life. Biospace Best Place to Work 2024!

139 Series C $125.39M

Waltham, United States

Biotechnology Health Care +1

ImmunAbs Inc.

ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope f...

11 Series B

Biotechnology Health Care +1

NeuroVia

Dedicated to halting the progression of severe neurological disorders and improving patien...

Series A $14.00M

Biopharma Biotechnology +1

BioAegis Therapeutics, Inc.

Commercializing a key component of the immune system, #Gelsolin, for infectious, inflammat...

13 Venture round $42.32M

Biotechnology Health and Wellness

Amplo Biotechnology

Pioneering AAV therapies for neuromuscular junction diseases, targeting congenital myasthe...

3 Grant $2.24M

Biotechnology Health Care +1

THRASOS LIMITED

Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...

2 Series D $56.00M

Biotechnology Health Care +2

Thymmune Therapeutics

Biotech firm developing thymic cell therapies to restore immune function using machine lea...

26 Seed $44.30M

Cambridge, United States

Biotechnology Health and Wellness

About Imago BioSciences, Inc.

Imago BioSciences, established in 2012 and headquartered in Redwood City, California, is committed to advancing state-of-the-art science into innovative treatments for challenging diseases. The company's last investment of $80.00M in Series C took place on 19 November 2020. Imago BioSciences focuses on a select group o...

Business keywords

Clinical Development, Therapeutics, Innovative Treatments, Orphan Diseases, State-of-the-art Science, Disease Progression, Transformative Therapies, Medical Research, Financial Support, Investors, Therapeutic Innovation, Redwood City, California

Frequently Asked Questions

Companies similar to Imago BioSciences, Inc. include Evommune, AGY Therapeutics, AAVantgarde, Rezolute, Inc., Solu Therapeutics. They work in Biotechnology and Health and Wellness and share Imago BioSciences, Inc.'s focus on disease progression, orphan diseases and medical research.

Bounce Watch lists 12 companies that share Imago BioSciences, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Imago BioSciences, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Imago BioSciences, Inc. Profile Evommune Alternatives AGY Therapeutics Alternatives AAVantgarde Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Imago BioSciences, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.